EUVIMEDEUVIMED entdecken
Crossref

Prior Authorization in Primary Total Hip Arthroplasty: Delays Without Financial Gains

Elizabeth A Abe, Juan D Lizcano, Saad Tarabichi, Nihir Parikh, Matthew B Sherman, Chad A Krueger, P Maxwell Courtney

The Journal of Arthroplasty · 2026-05 · 41 (5) · 1361-1369

DOI: 10.1016/j.arth.2025.09.025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2026-05. Verfasst von Elizabeth A Abe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Prior Authorization. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Prior authorization (PA) has been implemented by payers to reduce unnecessary health-care utilization. However, obtaining PA has been shown to increase the administrative burden and delay access to care. To our knowledge, financial burden and cost-effectiveness of PA in total hip arthroplasty (THA) are yet to be determined. The purpose of this prospective study was to quantify the costs associated with obtaining PA in primary THA patients. METHODS: A matched series of 1,788 patients undergoing primary THA with a single, commercial insurance payer from 2020 to 2022 at our institution was included. Data on PA status, number of services utilized, and total claims cost of nonoperative treatment received in the year before THA and incurred from the initial surgery request date to date of surgery were prospectively collected and analyzed. RESULTS: When comparing matched cohorts, no difference was found to exist among mean claim costs in the year before THA ($308 ± 220 in PA required versus $316 ± 264 in the no PA cohort, standardized mean difference [SMD) = 0.032) and incurred from initial surgery request date to date of THA ($295 ± 200 in PA required versus $305 ± 249 in the no PA cohort, SMD = 0.041). However, patients who required PA experienced a significantly longer duration from the initial surgery request date to the date of THA (43 ± 39 versus 39 days ±37, SMD = 0.083). CONCLUSION: In the present study, obtaining PA was found to be an ineffective cost-saving measure in patients undergoing primary THA. Additionally, THA patients who required PA experienced significantly longer wait times before undergoing THA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, Replacement, HipPrior AuthorizationHumansMaleFemaleMiddle AgedAgedProspective StudiesCost-Benefit AnalysisAdult

Stichwörter der Autor:innen

commercial payerscost-ineffectivedelays to surgeryprior authorizationtotal hip arthroplasty

Autor:innen und Institutionen

  • Rothman Orthopaedic Institute at Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Department of Orthopaedic Surgery, Cleveland Clinic Florida, Weston, Florida.
  • Department of Orthopaedic Surgery, Mayo Clinic Arizona, Phoenix, Arizona.

Zitieren

APA

Abe, E. A., Lizcano, J. D., Tarabichi, S., Parikh, N., Sherman, M. B., Krueger, C. A., & Courtney, P. M. (2026). Prior Authorization in Primary Total Hip Arthroplasty: Delays Without Financial Gains. The Journal of Arthroplasty, 41(5), 1361-1369. https://doi.org/10.1016/j.arth.2025.09.025

Vancouver

Abe EA, Lizcano JD, Tarabichi S, Parikh N, Sherman MB, Krueger CA, et al. Prior Authorization in Primary Total Hip Arthroplasty: Delays Without Financial Gains. The Journal of Arthroplasty. 2026;41(5):1361-1369. doi:10.1016/j.arth.2025.09.025

BibTeX
@article{Abe2026,
  author = {Abe, Elizabeth A and Lizcano, Juan D and Tarabichi, Saad and Parikh, Nihir and Sherman, Matthew B and Krueger, Chad A and Courtney, P Maxwell},
  title = {Prior Authorization in Primary Total Hip Arthroplasty: Delays Without Financial Gains},
  journal = {The Journal of Arthroplasty},
  year = {2026},
  volume = {41},
  number = {5},
  pages = {1361--1369},
  doi = {10.1016/j.arth.2025.09.025}
}
Kostenlos starten →